RT Journal Article
SR Electronic
T1 Testing out of quarantine
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.29.21250764
DO 10.1101/2021.01.29.21250764
A1 McGowan, Lucy D’Agostino
A1 Lee, Elizabeth C.
A1 Grantz, Kyra H.
A1 Kucirka, Lauren M.
A1 Gurley, Emily S.
A1 Lessler, Justin
YR 2021
UL http://medrxiv.org/content/early/2021/02/01/2021.01.29.21250764.abstract
AB Since SARS-CoV-2 emerged, a 14-day quarantine has been recommended based on COVID-19”s incubation period. Using an RT-PCR or rapid antigen test to “test out” of quarantine is a frequently proposed strategy to shorten duration without increasing risk. We calculated the probability that infected individuals test negative for SARS-CoV-2 on a particular day post-infection and remain symptom free for some period of time. We estimate that an infected individual has a 20.1% chance (95% CI 9.8-32.6) of testing RT-PCR negative on day five post-infection and remaining asymptomatic until day seven. We also show that the added information a test provides decreases as we move further from the test date, hence a less sensitive test that returns rapid results is often preferable to a more sensitive test with a delay.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funding from State of California Institute of Technology (19-13081) (ECL, KHG, JL), Johns Hopkins Hospital (ECL, JL), and Bloomberg Philanthropies (ECL, KHG, ESG, JL)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and R code needed to reproduce the results are provided. https://lucymcgowan.github.io/covidsens/articles/articles/figures.html https://github.com/lucymcgowan/covidsens